Discovery of a novel NAMPT inhibitor that selectively targets NAPRT-deficient EMT-subtype cancer cells and alleviates chemotherapy-induced peripheral neuropathy.
Theranostics
; 13(14): 5075-5098, 2023.
Article
en En
| MEDLINE
| ID: mdl-37771778
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
Theranostics
Año:
2023
Tipo del documento:
Article